NFE2L2 and inflammatory bowel disease: Wu et al. [52] worked on an in vitro study with LPS-induced Caco-2 intestinal epithelial cells (colitis model) to evaluate the effects of paeoniflorin against Nrf2 deactivation during this model of IBD.